Search

Introduction: Kidney allograft survival has increased significantly in the past few decades. However, the more potent immunosuppression has also resulted in a higher incidence of infections including BK virus nephropathy (BKVN). The profile of kidney transplant (KT) recipients including age, basic kidney disease, comorbidities, dialysis vintage, and type of kidney donor in India is different from that of high-income countries. There are very few studies on the incidence and outcomes of BKVN from India. We studied the incidence, clinical features, and the impact of a screening strategy on patients with BKVN at our center. Materials and Methods: This was a single-center retrospective record-based study. We screened the medical records of all KT recipients at our center from March 2012 to December 2020 for patients who were diagnosed with BKVN. We compared the incidence of BKVN before and after the implementation of a proactive screening strategy in 2017. Results: From March 2012 to December 2020, a total of 212 KTs were performed at our center. Twenty-eight patients were diagnosed to have BKVN at this time. The incidence of BKVN in our study was 13.2%. The incidence of BKVN before routine screening was initiated at our center was 11.3% whereas it was 13.6% after routine screening was initiated. Graft loss from BKVN was 7.14%. Conclusion: The incidence of BKVN at our center is higher than previously reported in India; however, the rate of graft loss is low. A proactive screening strategy using nucleic acid test may allow early detection of BKVN and may have a beneficial impact on graft outcomes. [ABSTRACT FROM AUTHOR]

Background: India performed 7936 kidney transplantation operations in 2018 with living donor as the source in 85%. Identifying a living kidney donor (LKD) is difficult due to medical, social, and regulatory barriers. In addition, only a proportion of patients who volunteer may be able to donate eventually. Despite living donors being the predominant source, there are very few studies addressing the factors influencing living donor kidney donation in India. Methods: We analyzed data from our prospective LKD registry between July 1, 2011 and June 31, 2018. Demographic details, medical history, serum creatinine, and measured glomerular filtration rate (mGFR), blood pressure and the eventual outcome of LKD evaluation, including reason for noneligibility were collected. In a prospective cohort of 12 LKDs, renal functional reserve was studied using protein loading and dietary protein intake was measured from urine urea nitrogen excretion. Results: Over a period of 81 months, 316 LKDs were enrolled in our program. On 101 instances factors related to recipients prevented transplantation and on 92 occasions donor related factors precluded donation. Among 182 medically eligible LKDs with no evidence of CKD, only 33% had mGFR >90 ml/min/1.73 m2. Based on our institutional criteria, 22% of LKDs with mGFR <70 ml/min/1.73 m2 were ineligible solely based this criterion. Eventually, only 32% of enrolled LKDs were accepted for donation. Dietary protein intake was low in all 12 LKDs studied, only one had mGFR >90 ml/min/1.73 m2. Eight LKDs with mGFR <90 ml/min/1.73 m2 showed renal functional reserve of more than 20% with protein loading. Conclusion: Only one-third of voluntary kidney donors enrolled for evaluation were eventually able to donate their kidney. Low mGFR in otherwise apparently healthy LKDs was an important reason precluding kidney donation. Only 33% of individual found medically fit for donation had a mGFR ≥90 ml/min/m2 at our center. Low dietary protein intake may be a factor contributing to low mGFR in healthy LKDs. [ABSTRACT FROM AUTHOR]

Background: Although malignant hypertension begets multiple target organ damage, there is limited data on patients with severe renal injury and evident malignant hypertension in renal histopathology. Methods: We assessed the baseline demographic, histopathological findings and clinical outcomes in this retrospective analysis of patients with biopsy-proven malignant hypertension. Results: Thirty cases were analysed, the mean age of patients was 40 ± 11.5 years, 28 (93.3%) were males and the average systolic and diastolic blood pressures at hospitalisation were 197.04 ± 24.14 and 117.41 ± 18.31 mmHg, respectively. Severe retinopathy was seen in 10 (33.3%). The median eGFR at admission was 6.3 (IQR 4.4--9.15) mL/min and 21 (72.4%) needed dialysis. Nine (30%) cases with glomerular crescents were having the primary glomerular disease (7 IgAN, 1 C3 glomerulonephritis, 1 membranoproliferative glomerulonephritis) and 17 (56.6%) had thrombotic microangiopathy. Three-month ESRD free survival was 34.5% (n = 10) and the ESRD cohort had more incidence of dialysis requiring kidney injury at presentation (94.4% vs. 40% in the non-ESRD cohort). Patient survival at 1 year was 50%. Isolated malignant hypertension, differed from others with regard to lesser incidence of severe retinopathy, less glomerular sclerosis (29.61 ± 15.86 vs. 48.45% ± 30.78; P = 0.03), absence of crescents (P = 0.02), more incidence of tuft wrinkling (100% vs. 35%, P = 0.00) and total vessel occlusion (P = 0.02). Conclusion: Clinicopathologically, accelerated essential hypertension differs from hypertension of glomerular disease. Degree of kidney injury at presentation is risk predictor for long-term morbidity in malignant hypertension. [ABSTRACT FROM AUTHOR]